


Healthcare News Roundup: Venture Capital
HSMN NewsFeed - 22 Jul 2021
Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
HSMN NewsFeed - 13 Jul 2021
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
HSMN NewsFeed - 8 Jul 2021
Theolytics expands Series A financing and welcomes M Ventures as a new investor
Theolytics expands Series A financing and welcomes M Ventures as a new investor
HSMN NewsFeed - 18 Jun 2021
Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
HSMN NewsFeed - 16 Jun 2021
Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members
Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members
HSMN NewsFeed - 16 Jun 2021
KAHR Announces $46.5 Million Financing to Advance its Multifunctional Immunotherapeutic Pipeline
KAHR Announces $46.5 Million Financing to Advance its Multifunctional Immunotherapeutic Pipeline
HSMN NewsFeed - 2 Jun 2021
Prytime Medical Closes Oversubscribed $6M Inside Funding Round to Fuel Commercialization Growth
Prytime Medical Closes Oversubscribed $6M Inside Funding Round to Fuel Commercialization Growth
HSMN NewsFeed - 1 Jun 2021
Kineta Closes $10 Million Financing Round to Advance Anti-VISTA Immuno-oncology Program
Kineta Closes $10 Million Financing Round to Advance Anti-VISTA Immuno-oncology Program
